RxDoctor Payments Data

Pratap Singh

Clinical Cardiac Electrophysiology · Ashland, KYNPI 1417203001

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (54.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medtronic accounts for 66.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2019 at $8,725 and has fallen 88.7% since, to $986 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in KY, where the typical reported total is $16,637.

$14,105in general payments, 2019–2025

Across 171 payments — averaging $82.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$9K
  • Boston Scientific$2K
  • Biosense Webster, Inc.$619
  • Novartis$531
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$384
  • Abbott$376
  • plus $1K from 20 others

What the payments were for

  • Grants$7,65054%
  • Travel & lodging$1,94314%
  • Food & beverage$4,38531%
  • Education$1271%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,105 in reported general payments places this provider in the 35th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

See all clinical cardiac electrophysiology providers in Kentucky

Medicare billing

Part B allowed, 2024
$179,020
Medicare patients
745
Services billed
2,091

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban91$101,835
Dofetilide36$4,701
Metoprolol Succinate149$1,831
Midodrine Hcl23$1,807
Diltiazem 24hr Er (Cd)Diltiazem Hcl49$1,672
Flecainide Acetate35$1,266
SotalolSotalol Hcl66$927
Nifedipine ErNifedipine20$627
Sucralfate44$582
Amiodarone Hcl46$528
Isosorbide Mononitrate ErIsosorbide Mononitrate43$424
Carvedilol41$267
Pantoprazole Sodium31$247
Warfarin Sodium19$240
ClopidogrelClopidogrel Bisulfate16$177

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$131$101,83591 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 57 clinical cardiac electrophysiology providers in Kentucky.

Other clinical cardiac electrophysiology in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →